- Market Capitalization, $K 1,584,423
- Shares Outstanding, K 39,930
- Annual Sales, $ 0 K
- Annual Income, $ -60,330 K
- 60-Month Beta N/A
- Price/Sales N/A
- Price/Cash Flow N/A
- Price/Book 7.66
|Period||Period Low||Period High||Performance|
| || |
+4.10 (+11.52%)since 05/11/21
| || |
-1.24 (-3.03%)since 03/11/21
Mental health is on the decline all over the world. In fact, as you read this, nearly 264 million ...
/PRNewswire/ -- The illegal drugs of the 1960's are becoming highly valued drugs for various new therapeutic uses across a growing list of maladies. The door of previously prohibited drugs has been opening...
COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that members of its management...
LONDON, June 03, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) ("COMPASS"), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental...
According to a report from ResearchAndMarkets, the global psychedelic drugs market could be worth $10.75 ...
With psychedelics, mental health care may never be the same. All as some of the nation’s “top ...
, /PRNewswire/ -- Recently, the use of psychedelics is evolving for the treatment of a variety of mental illnesses, including anxiety, depression, post-traumatic stress disorder and other related uses....
Healthcare companies are continuously looking for new treatment options for patients. One in particular, COMPASS Pathways (CMPS), is focused on using psilocybin therapy treat depression. The stock has...
, /PRNewswire/ -- Before 1970, promising research was being conducted on the potential therapeutic effects of a broad category of psychedelic drug compounds, including substances such as psilocybin, DMT...
Nearly 10 million people struggle with Parkinson’s disease at the moment.While there is no cure ...
|3rd Resistance Point||41.65|
|2nd Resistance Point||40.83|
|1st Resistance Point||40.25|
|1st Support Level||38.85|
|2nd Support Level||38.03|
|3rd Support Level||37.45|